Literature DB >> 21661079

Functional association of the N-terminal residues with the central region in glucagon-related peptides.

James T Patterson1, Jonathan W Day, Vasily M Gelfanov, Richard D DiMarchi.   

Abstract

GLP-1 is an incretin peptide involved in the regulation of glucose metabolism and the glucose-dependent stimulation of insulin secretion. Ex-4 is a paralog of GLP-1 that has comparable GLP-1R potency but extended physiological action. GLP-1 and Ex-4 are helical peptides that share ∼50% sequence homology but differ at several residues, notably the second amino acid which controls susceptibility to DPP-IV cleavage. This single amino acid difference yields divergent receptor potency when studied in the context of the two hormone sequences. Ex-4 uniquely tolerates Gly2 through select amino acid differences in the middle region of the peptide that are absent in GLP-1. We report that substitution of Ex-4 amino acids Glu16, Leu21, and Glu24 to the GLP-1 sequence enabled Gly2 tolerance. The coordination of the N-terminus with these central residues shows an interaction of substantial importance not only to DPP-IV stability but also to receptor activation. Extension of this observation to glucagon-based co-agonist peptides showed different structural requirements for effective communication between the N-terminus and the mid-section of these peptides in achieving high potency agonism at the GLP-1 and GCGRs.
Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21661079     DOI: 10.1002/psc.1385

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  7 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Design of Potent and Proteolytically Stable Oxyntomodulin Analogs.

Authors:  Avinash Muppidi; Huafei Zou; Peng Yu Yang; Elizabeth Chao; Lance Sherwood; Vanessa Nunez; Ashley K Woods; Peter G Schultz; Qing Lin; Weijun Shen
Journal:  ACS Chem Biol       Date:  2016-01-04       Impact factor: 5.100

3.  Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.

Authors:  Anandan Palani; Andrea R Nawrocki; Federica Orvieto; Elisabetta Bianchi; Emanuela Mandić; Antonello Pessi; Chunhui Huang; Qiaolin Deng; Nathalie Toussaint; Erika Walsh; Vijay Reddy; Eric Ashley; Huaibing He; Sheena Mumick; Brian Hawes; Donald Marsh; Mark Erion; Ravi Nargund; Paul E Carrington
Journal:  ACS Med Chem Lett       Date:  2022-07-21       Impact factor: 4.632

4.  Peptide lipidation stabilizes structure to enhance biological function.

Authors:  Brian P Ward; Nickki L Ottaway; Diego Perez-Tilve; Dejian Ma; Vasily M Gelfanov; Matthias H Tschöp; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-09-05       Impact factor: 7.422

5.  A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction.

Authors:  James T Patterson; Pengyun Li; Jonathan W Day; Vasily M Gelfanov; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-01-16       Impact factor: 7.422

6.  Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.

Authors:  Giuseppe Deganutti; Yi-Lynn Liang; Xin Zhang; Maryam Khoshouei; Lachlan Clydesdale; Matthew J Belousoff; Hari Venugopal; Tin T Truong; Alisa Glukhova; Andrew N Keller; Karen J Gregory; Katie Leach; Arthur Christopoulos; Radostin Danev; Christopher A Reynolds; Peishen Zhao; Patrick M Sexton; Denise Wootten
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

7.  PVN pathways controlling energy homeostasis.

Authors:  Jennifer W Hill
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.